GSA Capital Partners’s Aravive, Inc. Common Stock ARAV Stock Holding History

GSA Capital Partners’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,977,407	Closed	-$245K	–	2069
2023 Q4	$245K	Buy	+1,977,407	New	+$271K	0.02%	1219
2021 Q3	–	Sell	-88,102	Closed	-$527K	–	1862
2021 Q2	$527K	Buy	88,102 +37,587	+74%	+$199K	0.06%	587
2021 Q1	$333K	Buy	+50,515	New	+$332K	0.06%	582
2018 Q4	–	Sell	-28,111	Closed	-$236K	–	1832
2018 Q3	$236K	Sell	28,111 -19,339	-41%	-$204K	0.01%	1429
2018 Q2	$577K	Buy	47,450 +20,867	+78%	+$215K	0.03%	1083
2018 Q1	$263K	Buy	26,583 +11,983	+82%	+$135K	0.01%	1361
2017 Q4	$193K	Buy	+14,600	New	+$188K	0.01%	1419

Other funds holding ARAV

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GSA Capital Partners's ARAV Position: Q1 2024 in Review

GSA Capital Partners sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2024, closing a stake of 1,977,407 shares — an estimated $245K sold.

GSA Capital Partners first reported a position in ARAV in Q4 2017 and held it in 7 quarters. The position peaked at $577K in Q2 2018. 3 funds tracked by Wall St. Rank hold ARAV as of Q1 2024.

GSA Capital Partners reported no remaining Aravive, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
GSA Capital Partners sold 1,977,407 Aravive, Inc. Common Stock shares in Q1 2024, an estimated $245K.
GSA Capital Partners first reported a position in Aravive, Inc. Common Stock in Q4 2017 and held it in 7 quarters.
GSA Capital Partners's Aravive, Inc. Common Stock position peaked at $577K in Q2 2018.
3 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2024.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.